ACE and hypertensive disorder: In this brief correspondence piece, the authors postulate that patients with hypertension and diabetes treated with angiotensin-converting enzyme (ACE) inhibitors or angiotensin II type-I receptor blockers (ARBs) are at increased risk of developing severe and fatal COVID-19.